(Reuters) - The U.S. Food and Drug Administration's staff expressed concerns over the risk of incorrectly administering Colleguim Pharmaceuticals Inc's long-acting opioid painkiller.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49b2e19f/sc/14/l/0L0Sreuters0N0Carticle0C20A150C0A90C0A90Cus0Ecollegium0Epharm0Efda0EidUSKCN0AR91JX20A150A90A90DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
No comments:
Post a Comment